Patients Discontinuing Weight-Loss Injections Regain Weight at a Quadrupled Rate Compared to Dieters

New research indicates that patients who stop using blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover lost weight far faster than those who end traditional diet and exercise plans.

Research printed in a leading health publication points out that while overweight individuals can lose substantial amounts of their total mass while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month once they quit.

"People purchasing such drugs should be informed of the risk of rapid rebound weight gain when the medication concludes," cautioned researcher Dr. Susan Jebb.

This pace of regain implies a return to original mass within about a year and a half.

Comparing Approaches

The analysis, which looked at 37 of trials involving over 9,000 of participants, contrasted the effects of these new drugs with other pills.

Scientists note that individuals who lose weight through diet and exercise typically have a less rapid creep back—perhaps 0.1 kg a month—post-intervention.

The Reason for the Quick Rebound

Experts suggest the way of the drugs is key to understanding the accelerated regain.

The injections mimic a natural hormone called GLP-1, which controls feelings of fullness.

"Artificially providing GLP-1 levels far above than the body's typical production may cause the system to produce less of its endogenous hormone, and could diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition expert.

"Discontinuation of this GLP-1 'fix' results in hunger is no longer kept in check, making overeating a significant risk."

An Ongoing Condition?

Medical guidelines recommend the injections for individuals with obesity-related health risks, alongside prescribed diet and exercise modifications.

Professionals contend that, given the significant potential of weight regain, the treatment is often long-term.

This view is reinforced by pharmaceutical companies, who say that the results "underscore the chronic nature of excess weight," akin to managing conditions like hypertension.

Patient Experiences

People who have come off the medication describe a powerful resurgence of cravings.

"I experienced a trigger flipping and you're instantly ravenous," described one woman.

This difficulty is compounded if users have not developed lasting lifestyle or habit changes during treatment.

Significant Interest

Recent estimates suggest that millions of people in the UK have used these injections in the last 12 months, with desire being substantial.

• Use is greater among women compared to males.
• The middle-aged demographic shows the highest usage rates.
• Many access the medications through private prescriptions rather than public health services.

In conclusion, experts emphasize that while GLP-1 drugs are powerful tools for shedding pounds, they are not a permanent solution and lasting health benefits hinges on ongoing behavioural management.